PCN112 Estimating Resources Utilization and Health Care Costs Related to Colorectal Cancer Patients in Saudi Arabia

Abstract

This study aimed to estimate the resources utilization and costs of colorectal cancer in Saudi Arabia. A retrospective single-centered cohort study of all CRC patient from January 2016 to December 2019, all patient’s information was extracted from the Electronic Health Record of King Khalid University Hospital (KKUH). The study included all medical management cost of CRC in patients (≥18 years) with confirmed diagnosis of colorectal cancer, and excluded patient who did not receive any kind of medical management for CRC, or files with missing information. The total cost was calculated according to KKUH own price. A total of 326 colorectal patients were eligible for this study. Around two thirds of the cases were male and most of the patient 89% were Saudi. The average age for men was 59.2 and for women was 55.27. The total direct medical costs for all colorectal cancer patients was $31.5 million. Around half of cases were in stage 3. The annual cost per patients were $ 96,800. Overall, our analysis found that the costs related to medication were the major driver healthcare spending among all study population (45%) followed by surgery costs (27%). The costs related to hospitalization accounted for (14%) and laboratory cost represent (7%) of total cost. Costs related to radiotherapy had the lowest impact on total spending (2%). Cost were considerably increase as stage increase were the cost per patient for stage 1 was $50,728 and it is increase to over $93,333 in stage 4. This study presented various cost details for colorectal cancer which represent a substantial cost to Saudi healthcare budget and this cost is expected to increase significantly in the future because of expected growth of aging of the population and availability of newly innovated and costly treatment.